Tavros was founded with a mission to discover novel targeted cancer therapies using cutting edge genomics technologies to improve outcomes for cancer patients.

Our leadership team is comprised of successful serial entrepreneurs with deep expertise in functional genomics, tumor genetics and drug discovery.

Nikki Heron


Eoin McDonnell

CEO, Co-founder, Board Member

Kris Wood

Co-founder, Board Member

Assoc. Professor, Duke University
Robert Long

Board Member

Co-founder Piedmont Capital Investments

Interested in joining our team?